Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Oral Maxillofac Surg ; 66(2): 277-85, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18201609

RESUMO

PURPOSE: Cranial defect reconstruction presents 2 challenges: induction of new bone formation, and providing structural support during the healing process. This study compares quantity and quality of new bone formation based on various materials and support frameworks. MATERIALS AND METHODS: Eighteen dogs underwent surgical removal of a significant portion of their cranial vault. Demineralized bone matrix was used to fill the defect in all animals. In 9 dogs, recombinant human bone morphogenetic protein-2 (rhBMP-2) was added, while the other 9 served as the non-rhBMP-2 group. In each group, 3 animals were fixed with cobalt chrome plates, 3 with adding platelet-rich plasma, and 3 fixed with a Lactosorb (Walter Lorenz Surgical, Inc, Jacksonville, FL) resorbable mesh. Necropsy was done at 12 weeks postoperative. Histomorphometry, density, and mechanical properties of the regenerate were analyzed. RESULTS: The non-rhBMP-2 groups showed minimal substitution of demineralized bone matrix with new bone, while only sporadic remnants of demineralized bone matrix were present in the rhBMP-2 groups. The defect showed more new bone formation (P < .001) and density (P < .001) in the rhBMP-2 groups by Kruskal-Wallis test. The area of new bone was not significantly different among the rhBMP-2 subgroups. The resorbable mesh struts showed no sign of bone invasion or substitution. In the non-rhBMP-2 resorbable mesh group, demineralized bone matrix almost totally disintegrated without replacement by new bone. CONCLUSIONS: The addition of rhBMP-2 to demineralized bone matrix accelerated new bone formation in large cranial defects, regardless of the supporting framework or the addition of platelet-rich plasma. The use of a resorbable mesh in such defects is advisable only if rhBMP-2 is added.


Assuntos
Proteínas Morfogenéticas Ósseas/uso terapêutico , Regeneração Óssea/efeitos dos fármacos , Substitutos Ósseos/uso terapêutico , Transplante Ósseo/métodos , Crânio/cirurgia , Fator de Crescimento Transformador beta/uso terapêutico , Animais , Materiais Biocompatíveis , Proteína Morfogenética Óssea 2 , Placas Ósseas , Substitutos Ósseos/química , Transplante Ósseo/diagnóstico por imagem , Cobalto , Cães , Humanos , Masculino , Plasma Rico em Plaquetas , Crânio/diagnóstico por imagem , Telas Cirúrgicas , Ultrassonografia
2.
Ann Acad Med Singap ; 36(11): 911-9, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18071597

RESUMO

OBJECTIVE: This study was designed to investigate the optimal combination of known osteogenic biomaterials with shape conforming struts to achieve calvarial vault reconstruction, using a canine model. METHODS: Eighteen adolescent beagles were divided equally into 6 groups. A critical size defect of 6 x 2 cm traversed the sagittal suture. The biomaterials used for calvarial reconstruction were demineralised perforated bone matrix (DBM), recombinant human bone morphogenetic protein-2 (rhBMP2) and autogenous platelet-rich plasma (PRP). The struts used were cobalt chrome (metal) or resorbable plate. The groupings were as follows: 1) DBM + metal, 2) DBM + PRP + metal, 3) DBM + PRP + resorbable plate, 4) DBM + rhBMP2 + metal, 5) DBM + rhBMP2 + PRP + metal, and 6) DBM + rhBMP2 + resorbable plate. Animals were euthanised at 3 months post-surgery. There was no mortality or major complications. Analysis was performed macroscopically, histologically, and with computed tomography (CT). RESULTS: There was complete bony regeneration in the rhBMP2 groups only. Non-rhBMP2 groups had minimal bony ingrowth from the defect edges and on the dural surface, a finding confirmed by CT scan and histology. PRP did not enhance bone regeneration. Shape conformation was good with both metal and resorbable plate. CONCLUSION: rhBMP2 but not PRP accelerated calvarial regeneration in 3 months. The DBM in the rhBMP2 groups were substituted by new trabecular bone. Shape molding was good with both metal and resorbable plate.


Assuntos
Regeneração Óssea/fisiologia , Modelos Animais , Crânio/patologia , Animais , Materiais Biocompatíveis , Proteína Morfogenética Óssea 2 , Proteínas Morfogenéticas Ósseas/farmacologia , Cães , Cuidados Pós-Operatórios , Proteínas Recombinantes/farmacologia , Procedimentos de Cirurgia Plástica , Crânio/crescimento & desenvolvimento , Crânio/cirurgia , Fator de Crescimento Transformador beta/farmacologia
3.
Am J Orthop (Belle Mead NJ) ; 35(12): 562-7, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17243405

RESUMO

The osteoinductive capacity of demineralized bone matrix (DBM) has led to wide use of this material for surgical reconstruction. Preparation of DBM often includes sterilization with ethylene oxide, disinfection with various chemical agents, or irradiation. Exposure to hydrogen peroxide (H2O2) is used for both sterilization and bleaching of bone, the latter primarily for cosmetic reasons. We investigated the effect of H2O2, on the osteoinductive capacity of DBM. Cortical bone implants prepared from rat femurs were placed into 3% H2O2 solution. Control specimens were not exposed to H2O2. Bones were then lipid-extracted, demineralized, sterilized with ethylene oxide, and freeze-dried in an identical manner. Allografts were implanted into rat hosts for 1 to 3 weeks. Osteoinduction proceeded rapidly in implants not exposed to H2O2, with chondrocytes and new bone appearing in the implant. After 3 weeks, perforations in the implant were largely replaced with new bone. In contrast, osteoinduction did not occur in implants treated with H2O2. Perforations in H2O2-treated implants were filled with vascularized fibrous tissue, but no cartilage or bone. These findings reveal that H2O2 used for disinfection or bleaching of DBM can abolish its osteoinductive capacity in rats.


Assuntos
Matriz Óssea/efeitos dos fármacos , Peróxido de Hidrogênio/farmacologia , Osteogênese/efeitos dos fármacos , Oxidantes/farmacologia , Animais , Técnica de Desmineralização Óssea , Transplante Ósseo , Fêmur/citologia , Fêmur/efeitos dos fármacos , Fêmur/transplante , Ratos , Ratos Long-Evans
4.
J Orthop Res ; 22(6): 1358-61, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15475221

RESUMO

In 1987 it was anticipated that unsterilized tissues would transmit virus diseases such as hepatitis and HIV-1 from infected donors so a freeze-drying process for musculoskeletal tissue was developed to include terminal ethylene oxide (EO) exposure for 14 h. We found no studies of EO efficacy when viruses were associated with human allografts so we studied the antiviral effect of terminal EO disinfection using all but the final freeze-drying phase of this clinical processing protocol (CPP). Specifically we looked at EO inactivation of HIV-1, a human hepatitis B surrogate and test viruses known to be highly resistant to disinfecting agents, including irradiation. Freeze-drying, ordinarily required after EO disinfection and part of the CPP, was not done. Suspensions of HIV-1, Bovine viral diarrhea, Reovirus type 3, Duck hepatitis B, Poliomyelitis and Canine parvovirus were adsorbed on glass, demineralized bone powder, and preprocessed strips of femoral cortex, iliac wedges, cancellous blocks and patellar bone-tendon-bone preparations and subjected to EO disinfection. Test viruses were inactivated at the end of 7 h of EO disinfection, providing a safety factor in the CPP of at least 100%. Because allografts can transmit viruses, terminal EO disinfection should provide safer musculoskeletal allografts than non-disinfected tissues or those irradiated with a standard irradiation dose. New spontaneously appearing viruses would probably be inactivated with this terminal EO disinfection but they and viral bioweapons will require individual validation to assure viral inactivation.


Assuntos
Desinfetantes/farmacologia , Desinfecção/métodos , Óxido de Etileno/farmacologia , HIV-1/efeitos dos fármacos , Transplante Homólogo , Animais , Osso e Ossos , Vírus da Diarreia Viral Bovina/efeitos dos fármacos , Vírus da Hepatite B do Pato/efeitos dos fármacos , Humanos , Orthoreovirus Mamífero 3/efeitos dos fármacos , Músculo Esquelético , Parvovirus Canino/efeitos dos fármacos , Poliovirus/efeitos dos fármacos
5.
J Craniofac Surg ; 19(2): 383-92, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18362715

RESUMO

This study was designed to investigate the optimal combination of known osteogenic biomaterials with shape conforming struts to achieve calvarial vault reconstruction, using a canine model. Eighteen adolescent beagles were divided equally into 6 groups. A critical-size defect of 6 x 2 cm traversed the sagittal suture. The biomaterials used for calvarial reconstruction were demineralized perforated bone matrix (DBM), recombinant human bone morphogenetic protein 2 (rhBMP2), and autogenous platelet-rich plasma (PRP). The struts used were cobalt chrome (metal) or resorbable plate. The groupings were as follows: 1) DBM + metal, 2) DBM + PRP + metal, 3) DBM + PRP + resorbable plate, 4) DBM + rhBMP2 + metal, 5) DBM + rhBMP2 + PRP + metal, and 6) DBM + rhBMP2 + resorbable plate. Animals were killed at 3 months after surgery. There was no mortality or major complications. Analysis was performed macroscopically and histologically and with computed tomography. There was complete bony regeneration in the rhBMP2 groups only. Non-rhBMP2 groups had minimal bony ingrowth from the defect edges and on the dural surface, a finding confirmed by computed tomographic scan and histology. Platelet-rich plasma did not enhance bone regeneration. Shape conformation was good with both metal and resorbable plate. rhBMP2, but not PRP, accelerated calvarial regeneration in 3 months. The DBMs in the rhBMP2 groups were substituted by new trabecular bone. Shape molding was good with both metal and resorbable plate.


Assuntos
Doenças Ósseas/cirurgia , Osteogênese/fisiologia , Procedimentos de Cirurgia Plástica/métodos , Crânio/cirurgia , Implantes Absorvíveis , Animais , Materiais Biocompatíveis/uso terapêutico , Doenças Ósseas/patologia , Matriz Óssea/transplante , Proteína Morfogenética Óssea 2 , Proteínas Morfogenéticas Ósseas/uso terapêutico , Placas Ósseas , Regeneração Óssea/efeitos dos fármacos , Regeneração Óssea/fisiologia , Ligas de Cromo , Corantes , Suturas Cranianas/cirurgia , Modelos Animais de Doenças , Cães , Humanos , Processamento de Imagem Assistida por Computador , Imageamento Tridimensional , Ácido Láctico , Masculino , Osteogênese/efeitos dos fármacos , Plasma Rico em Plaquetas , Ácido Poliglicólico , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Proteínas Recombinantes/uso terapêutico , Crânio/patologia , Tomografia Computadorizada por Raios X , Fator de Crescimento Transformador beta/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa